Highlighted Events
PRAX-222 Receives Rare Pediatric Disease and Orphan Drug Designation
January 2021
RogCon Development Partner Praxis Precision Medicines to Present on PRAX-222 Program at SCN2A Family Virtual Conference
September 2020
PRIOR HEADLINES
Alex Nemiroff and Dr. Steven Petrou Presenting at Epilepsy Precision Medicine Conference
RogCon Sponsoring The SCN2A Family and Professional Conference
Dr. Steven Petrou Presents Data on Antisense Oligonucleotide Development Program for SCN2A Epilepsy at 2019 World Orphan Drug Congress
AES Late-Breaking Abstract Presentation: Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsies
In The News
November 10, 2017
August 11, 2015